Vietnam Pharmacy Retail Market Report 2022-2027: Significant Growth Expected, Driven by Consumer Preference Towards Online Pharmaceutical Shopping and Rising Incidences of Lifestyle Diseases – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vietnam Pharmacy Retail Market, By Market Structure (Organized v/s Unorganized), By Product Type, By Therapeutic Area, By Drug Type, By Pharmacy Location, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. Vietnam pharmacy retail market is projected to grow at a significant rate during the forecast period. The … [Read more…]

Continuous Renal Replacement Therapy (CRRT) – Global Market Trajectory & Analytics to 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Continuous Renal Replacement Therapy (CRRT) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026 Amid the COVID-19 crisis, the global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.4 Billion in the year 2022, is … [Read more…]

Global Gene Therapy Market Analysis Report 2022: M&As Rampant in the Gene Therapy Space – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gene Therapy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Gene Therapy Market to Reach $2.7 Billion by 2026 Amid the COVID-19 crisis, the global market for Gene Therapy estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2.7 Billion … [Read more…]

2022 In Vitro Diagnostic eCommerce Business Models Growth Opportunities Report: Disruptive Differentiation in Supply Chain Management Drives New Growth Potential – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic eCommerce Business Models Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This study assesses the eCommerce business potential across sectors, creating resilient healthcare and diagnostic market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable, cost-efficient business opportunities with new B2B products, customized outsourcing services, and … [Read more…]

Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)

With this recommendation, eligible patients in England, Wales and Northern Ireland will be able to access the first orally administered therapy for GPA/MPA, two main forms of ANCA-associated vasculitis (AAV) Launch of Tavneos® in the UK is expected in the next weeks ST. GALLEN, Switzerland–(BUSINESS WIRE)–Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to … [Read more…]

Second Google Vet Joins Suki as VP of Product and Design

Suki strengthens its leadership team in US and India and appoints Belwadi Srikanth as the new Vice President, Product and Design; along with Anmol Rastogi as Senior Director, Product Management REDWOOD CITY, Calif.–(BUSINESS WIRE)–Suki, the leader in voice artificial intelligence (AI) technology for healthcare, announced today that it has grown its product team with the … [Read more…]

Athersys, Inc. Announces Closing of $12 Million Registered Direct Offering

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX) today announced the closing of its previously announced registered direct offering with a single healthcare-focused U.S. institutional investor for the purchase of 48,000,000 shares of the Company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 48,000,000 shares of common stock at a combined … [Read more…]

QuidelOrtho Announces $300 Million Share Repurchase Authorization

Reflects QuidelOrtho’s confidence in its strong balance sheet and cash generation QuidelOrtho continues to prioritize investments in R&D, manufacturing capacity, and debt paydown SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors … [Read more…]

Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it has filed an amended complaint against Foresight Diagnostics. The amended complaint asserts a newly-issued patent in Personalis’ growing intellectual property portfolio relating to detection of molecular residual disease (MRD). The patent, US Patent No. 11,408,033 (the “‘033 patent”), … [Read more…]

MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

MISSISSAUGA, Ontario & PHOENIX–(BUSINESS WIRE)–MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 1:20 p.m. ET. Interested parties can access … [Read more…]